Valvular heart disease assessment of lesion severity
-
Upload
dr-awadhesh-sharma -
Category
Education
-
view
2.606 -
download
0
description
Transcript of Valvular heart disease assessment of lesion severity
![Page 1: Valvular heart disease assessment of lesion severity](https://reader035.fdocuments.us/reader035/viewer/2022081505/554b2442b4c905a2058b463a/html5/thumbnails/1.jpg)
Valvular Heart DiseaseValvular Heart DiseaseAssessment of Lesion severityAssessment of Lesion severity
Dr Awadhesh kumar sharma
DM Cardiology
PGIMER &Dr RML Hospital,New Delhi
![Page 2: Valvular heart disease assessment of lesion severity](https://reader035.fdocuments.us/reader035/viewer/2022081505/554b2442b4c905a2058b463a/html5/thumbnails/2.jpg)
In managing the patient with valvular heart disease (VHD) three major issues must be addressed:-
Assessment of the severity of disease, The effect the disease is having or is likely to have on the
patient and his/her cardiovascular system The timing and type of intervention to be used to correct
the lesion.
Braunwald’s Heart Disease: A Textbook of Cardiovascular Medicine. 8th ed. Philadelphia, PA: WB Saunders; 2007:1625-1712.
![Page 3: Valvular heart disease assessment of lesion severity](https://reader035.fdocuments.us/reader035/viewer/2022081505/554b2442b4c905a2058b463a/html5/thumbnails/3.jpg)
The distinction between mild, moderate and severe disease is thought crucial since it is believed that, in most cases, mild and moderate disease are tolerated indefinitely (unless severity worsens) and only severe disease (as defined) causes symptoms and cardiac dysfunction.
Braunwald’s Heart Disease: A Textbook of Cardiovascular Medicine. 8th ed. Philadelphia, PA: WB Saunders; 2007:1625-1712.
![Page 4: Valvular heart disease assessment of lesion severity](https://reader035.fdocuments.us/reader035/viewer/2022081505/554b2442b4c905a2058b463a/html5/thumbnails/4.jpg)
Classification of the severity of valve lesions should be based on multiple criteria, including the initial findings on the physical examination, which should then be correlated with data from a comprehensive TTE.
Intervention should primarily be performed on patients with severe VHD
Braunwald’s Heart Disease: A Textbook of Cardiovascular Medicine. 8th ed. Philadelphia, PA: WB Saunders; 2007:1625-1712.
![Page 5: Valvular heart disease assessment of lesion severity](https://reader035.fdocuments.us/reader035/viewer/2022081505/554b2442b4c905a2058b463a/html5/thumbnails/5.jpg)
Classification of progression of VHD
J Am Coll Cardiol. March 2014.Online first.
![Page 6: Valvular heart disease assessment of lesion severity](https://reader035.fdocuments.us/reader035/viewer/2022081505/554b2442b4c905a2058b463a/html5/thumbnails/6.jpg)
OBJECTIVE ASSESSMENT OF DISEASE SEVERITY
The physical examination In this age of high-tech diagnostic modalities, the physical
examination, and the skill applied when performing it, seem to be diminishing.
However, the importance of the physical exam cannot be overemphasized because it lays the Bayesian foundation for all tests that follow.
![Page 7: Valvular heart disease assessment of lesion severity](https://reader035.fdocuments.us/reader035/viewer/2022081505/554b2442b4c905a2058b463a/html5/thumbnails/7.jpg)
Mitral stenosis (MS)
Etiology Most commonly rheumatic fever ——rheumatic heart disease ( RHD ) Symptoms commence mostly in 2nd~4th decade 2/3 of all patients are female 25% of all patients with RHD have pure MS
40% have combined MS and mitral regurgitation (MR)
J Am Coll Cardiol. 1994;24:152-8.
![Page 8: Valvular heart disease assessment of lesion severity](https://reader035.fdocuments.us/reader035/viewer/2022081505/554b2442b4c905a2058b463a/html5/thumbnails/8.jpg)
Clinical features s/o severe MS
PND Pulmonary edema Orthopnea Atrial fibrillation Ortner syndrome Short A2-OS interval Long duration of diastolic murmur
J Am Coll Cardiol. 1994;24:152-8.
![Page 9: Valvular heart disease assessment of lesion severity](https://reader035.fdocuments.us/reader035/viewer/2022081505/554b2442b4c905a2058b463a/html5/thumbnails/9.jpg)
Laboratory examination
Electrocardiography (ECG)Left atrial enlargement Mitral valve P wave P-wave duration in lead II > 0.12 s Large terminal negative P force in lead V1
Right ventricular hypertrophy
Arrhythmia Premature atrial contraction → atrial fibrillation
![Page 10: Valvular heart disease assessment of lesion severity](https://reader035.fdocuments.us/reader035/viewer/2022081505/554b2442b4c905a2058b463a/html5/thumbnails/10.jpg)
Radiological findings
“Mitral valve heart”
Marked enlargement of LAEnlargement of RVDilatation of PA
Pulmonary congestionInterstitial edema (manifested as Kerley B lines)
![Page 11: Valvular heart disease assessment of lesion severity](https://reader035.fdocuments.us/reader035/viewer/2022081505/554b2442b4c905a2058b463a/html5/thumbnails/11.jpg)
EchocardiographyThe most valuable technique for diagnosing MS, and determining its severity
M-mode echoM-mode echo :: Thickened, calcified leaflets open poorly, close slowly (EF slope↓) The double peaks disappear Both leaflets move anteriorly during early diastole
Two-dimensional echo:Two-dimensional echo: Fusion, thickening, doming of the valve leaflets, and poor leaflet separation in diastole; mitral orifice area↓
Eur J Echocardiogr. 2009;10:1-25.
![Page 12: Valvular heart disease assessment of lesion severity](https://reader035.fdocuments.us/reader035/viewer/2022081505/554b2442b4c905a2058b463a/html5/thumbnails/12.jpg)
Mitral stenosis
Moderate MS
Severe MS
![Page 13: Valvular heart disease assessment of lesion severity](https://reader035.fdocuments.us/reader035/viewer/2022081505/554b2442b4c905a2058b463a/html5/thumbnails/13.jpg)
![Page 14: Valvular heart disease assessment of lesion severity](https://reader035.fdocuments.us/reader035/viewer/2022081505/554b2442b4c905a2058b463a/html5/thumbnails/14.jpg)
Hemodynamic changes
MS involves mainly LA and RV
1. Effect of MS on left atrioventricular pressure gradient and left atrial pressure (LAP)
MVA transvalvular gradient LAP
Normal 4 ~ 6cm2
Mild MS > 1.5cm2 <5 mmHg ↑
Moderate 1.0 ~ 1.5cm2 5-10mmHg ↑↑
Severe < 1.0cm2 ≥10mmHg 25mmHg
Eur J Echocardiogr. 2009;10:1-25.
![Page 15: Valvular heart disease assessment of lesion severity](https://reader035.fdocuments.us/reader035/viewer/2022081505/554b2442b4c905a2058b463a/html5/thumbnails/15.jpg)
Mitral stenosis
![Page 16: Valvular heart disease assessment of lesion severity](https://reader035.fdocuments.us/reader035/viewer/2022081505/554b2442b4c905a2058b463a/html5/thumbnails/16.jpg)
Doppler echoDoppler echo ::Most accurate noninvasive technique for quantifying the severity of MS
Spectrum Doppler: measure transvalvular gradient, MVAColor Doppler: display high velocity color jet
Provide other important informationCardiac chamber size (LA, RV)Left ventricular contractilityPulmonary arterial pressureOther coexisted valvular or congenital abnormalities Mural thrombi
Eur J Echocardiogr. 2009;10:1-25.
![Page 17: Valvular heart disease assessment of lesion severity](https://reader035.fdocuments.us/reader035/viewer/2022081505/554b2442b4c905a2058b463a/html5/thumbnails/17.jpg)
Cardiac catheterization Its value in assessment of patients with MS or suspected MS has been largely superseded by echocardiography
If surgery is planned, coronary angiography is performed to ascertain whether or not bypass grafting is indicated in patients at risk of having coexisting coronary artery disease
J Am Coll Cardiol. 1994;24:152-8.
![Page 18: Valvular heart disease assessment of lesion severity](https://reader035.fdocuments.us/reader035/viewer/2022081505/554b2442b4c905a2058b463a/html5/thumbnails/18.jpg)
2014 AHA/ACC Valvular Heart Disease Guidelines
J Am Coll Cardiol. March 2014.Online first.
![Page 19: Valvular heart disease assessment of lesion severity](https://reader035.fdocuments.us/reader035/viewer/2022081505/554b2442b4c905a2058b463a/html5/thumbnails/19.jpg)
Mitral regurgitation (MR)EtiologyMitral valve apparatus and/or LV structural and
functional abnormality
RHD: common(1/3); + MS and/ or aortic valve disease
Mitral valve prolapse (MVP) myxomatous degeneration, floppy and redundancy
Ischemic heart disease (or CAD) papillary muscle dysfunction
Mitral annular calcification
![Page 20: Valvular heart disease assessment of lesion severity](https://reader035.fdocuments.us/reader035/viewer/2022081505/554b2442b4c905a2058b463a/html5/thumbnails/20.jpg)
Severe dilatation of LV result in dilatation of the mitral annulus and lateral movement of papillary muscle
Infective endocarditis valve leaflets destruction, perforation, retraction; valve closure interfered by vegetation
Other causes: Rupture of the chordae congenital abnormalities obstructive hypertrophic cardiomyopathy
![Page 21: Valvular heart disease assessment of lesion severity](https://reader035.fdocuments.us/reader035/viewer/2022081505/554b2442b4c905a2058b463a/html5/thumbnails/21.jpg)
Hemodynamic changesMR involves mainly LA and LVChronic MRCompensation: MR→ LV volume↑→LV, LA↑→ LVEDV↑→ SV↑→ CO↑, EF↑
Decompensation: Left HF, LAP and LVEDP↑ → pulmonary congestion, pulmonary hypertension, right HF (hepatomegaly, edema, and ascites) CO↓
Acute MR MR →LA, LV volume↑→LVEDP↑→LAP↑→ ↓ pulmonary congestion, pulmonary edemaSV and CO↓
![Page 22: Valvular heart disease assessment of lesion severity](https://reader035.fdocuments.us/reader035/viewer/2022081505/554b2442b4c905a2058b463a/html5/thumbnails/22.jpg)
Clinical manifestationsSymptomsChronic MR Mild— no symptom Severe— left-sided heart failure Weakness, fatigue (CO↓) Dyspnea (pulmonary congestion)
RHD: symptoms occur late, once present, LV dysfunction is usually irreversible
MVP: asymptomatic, or atypical chest pain, palpitation, fatigue; in severe MR, left HF occur at late stage
Acute Mild— mild exertional dyspnea
Severe— acute left HF, pulmonary edema, or cardiac shock
Circulation. 2003;108:2432-2438.
![Page 23: Valvular heart disease assessment of lesion severity](https://reader035.fdocuments.us/reader035/viewer/2022081505/554b2442b4c905a2058b463a/html5/thumbnails/23.jpg)
Physical examination
Cardiac impulse at apex Hyperdynamic Displaced laterally, inferiorly (Chronic)
Changes of heart sounds S1↓(RHD) or normal (MVP, CAD) S3 (severe MR): prominent
Mid or late systolic click ( MVP ) ( Acute: P2↑ , S4 )
Circulation. 2003;108:2432-2438.
![Page 24: Valvular heart disease assessment of lesion severity](https://reader035.fdocuments.us/reader035/viewer/2022081505/554b2442b4c905a2058b463a/html5/thumbnails/24.jpg)
Systolic murmurRHD : Pansystolic, blowing, high-pitched murmurPansystolic, blowing, high-pitched murmur maximal at the apex Anterior valve lesion, radiate to the axilla and back Posterior leaflet abnormality, radiate to the base
MVP : mid- to late-systolic murmurDysfunction of papillary muscles: Variable (early, mid, late or holosystolic)
Rupture of the chordae: musical
(Acute MR: not pansystolic murmur, but lower-pitched,
decrescendo, and softer than the murmur of chronic MR)
Circulation. 2003;108:2432-2438.
![Page 25: Valvular heart disease assessment of lesion severity](https://reader035.fdocuments.us/reader035/viewer/2022081505/554b2442b4c905a2058b463a/html5/thumbnails/25.jpg)
Severe MR
Hyperdynamic LV type apex Systolic thrill over apex S3 Functional flow mid diastolic murmur
Circulation. 2003;108:2432-2438.
![Page 26: Valvular heart disease assessment of lesion severity](https://reader035.fdocuments.us/reader035/viewer/2022081505/554b2442b4c905a2058b463a/html5/thumbnails/26.jpg)
Laboratory examination
ECGChronic (severe) MR: LA dilation, Atrial fibrillation LV enlargement and non-specific ST-T changes
Acute MR: sinus tachycardia
Radiological findingsChronic (severe) MR: Cardiomegaly with LA, LV↑; pulmonary congestion, interstitial edema with Kerley B lines (left HF) C-shaped calcification of mitral annulus
Acute MR: Normal cardiac silhouette or mild LA dilation overt pulmonary congestion, edema
J Am Coll Cardiol. 1999;34:1137-44.
![Page 27: Valvular heart disease assessment of lesion severity](https://reader035.fdocuments.us/reader035/viewer/2022081505/554b2442b4c905a2058b463a/html5/thumbnails/27.jpg)
Echocardiography1 、 Display anatomy of the mitral valve apparatus Useful in determining the etiology of MR (2D)2 、 Confirm the existence of MR Doppler (color, spectrum): reveal high-velocity jet into LA
during systole Sensitivity~100%
Estimate the severity of MR < 4
cm2 Mild ( Color flow jet area ) 4~8 cm2 Moderate > 8
cm2 Severe
3 、 Measure cardiac chamber sizes, evaluate LV function, pulmonary artery pressure, provide data concerning other valvular lesions
J Am Coll Cardiol. 1999;34:1137-44.
![Page 28: Valvular heart disease assessment of lesion severity](https://reader035.fdocuments.us/reader035/viewer/2022081505/554b2442b4c905a2058b463a/html5/thumbnails/28.jpg)
Calculating (PISA)
Apical 4Ch view Narrow sector width Minimise depth Zoom Adjust Colour Doppler
alaising velocity (20-40 cm/s)
![Page 29: Valvular heart disease assessment of lesion severity](https://reader035.fdocuments.us/reader035/viewer/2022081505/554b2442b4c905a2058b463a/html5/thumbnails/29.jpg)
PISA
Measure the radius of the hemisphere. (red/blue interface)
– PISA radius =2πr2 (cm2)
• Mild MR: <0.4
• Severe MR:>1.0
![Page 30: Valvular heart disease assessment of lesion severity](https://reader035.fdocuments.us/reader035/viewer/2022081505/554b2442b4c905a2058b463a/html5/thumbnails/30.jpg)
Colour Doppler Indicators of Mitral Regurgitation Severity
Mild Moderate Severe
Colour Doppler
Jet area (cm2) Nyquist 50-60cm/s
<4 >10
Ratio of jet area to left atrial area (%)
<20 >40
Vena contracta width (cm)
<0.3 >0.7
PISA radius (cm) at Nyquist 40cm/s
<0.4 >1.0
![Page 31: Valvular heart disease assessment of lesion severity](https://reader035.fdocuments.us/reader035/viewer/2022081505/554b2442b4c905a2058b463a/html5/thumbnails/31.jpg)
Continuous wave and Pulse wave Doppler
Continuous wave spectral Strength
– Apical 4Ch view CW of regurgitant jet
• Faint in mild mitral regurgitation
• Denser in moderate and severe regurgitation.
![Page 32: Valvular heart disease assessment of lesion severity](https://reader035.fdocuments.us/reader035/viewer/2022081505/554b2442b4c905a2058b463a/html5/thumbnails/32.jpg)
Peak Mitral Valve E velocity
Increased mitral valve E velocity (>1.2m/s) may indicate significant regurgitation.
– Assumes ejection fraction is>40%)
Decreased mitral valve DT (<150msec) may indicate significant regurgitation.
– Assumes normal diastolic LV function.
![Page 33: Valvular heart disease assessment of lesion severity](https://reader035.fdocuments.us/reader035/viewer/2022081505/554b2442b4c905a2058b463a/html5/thumbnails/33.jpg)
Pulmonary Vein Systolic Flow Reversal
PW doppler 1cm into the pulmonary veins
– Systolic S (systolic) wave is normally larger than the D (diastolic) wave.
– If D wave is larger there is blunting of forward flow.
– S wave inversion demonstrates systolic flow reversal (indicative of severe MR).
![Page 34: Valvular heart disease assessment of lesion severity](https://reader035.fdocuments.us/reader035/viewer/2022081505/554b2442b4c905a2058b463a/html5/thumbnails/34.jpg)
Limitation
Eccentric jets may affect pulmonary vein flow
![Page 35: Valvular heart disease assessment of lesion severity](https://reader035.fdocuments.us/reader035/viewer/2022081505/554b2442b4c905a2058b463a/html5/thumbnails/35.jpg)
Determination of Pulmonary Artery Pressures at Rest and Exercise
![Page 36: Valvular heart disease assessment of lesion severity](https://reader035.fdocuments.us/reader035/viewer/2022081505/554b2442b4c905a2058b463a/html5/thumbnails/36.jpg)
Multimodality Indicators of Mitral Regurgitation Severity
Mild Moderate Severe
Multimodality
Regurgitant volume (mL/beat)
<30 30-59 >60
Regurgitant fraction (%)
<30 30-49 >50
Effective regurgitant orifice area (cm2)
<0.20 0.20-0.39 >0.40
![Page 37: Valvular heart disease assessment of lesion severity](https://reader035.fdocuments.us/reader035/viewer/2022081505/554b2442b4c905a2058b463a/html5/thumbnails/37.jpg)
Regurgitant Volume, Regurgitant Fraction and ERO
Regurgitant volume Step 1
– A4ch view measure diameter of the mitral annulus.
• CSAMV =0.785 X (mitral annulus diameter)2
![Page 38: Valvular heart disease assessment of lesion severity](https://reader035.fdocuments.us/reader035/viewer/2022081505/554b2442b4c905a2058b463a/html5/thumbnails/38.jpg)
Regurgitant volume
Step 2– Apical 4Ch view measure
the VTI of the mitral inflow (using PWD)
– Commonly at valve tip level.
• VTIMV in cm Step 3. Stroke Volume
– SVMV (mL/beat) =CSAMV X VTIMV
![Page 39: Valvular heart disease assessment of lesion severity](https://reader035.fdocuments.us/reader035/viewer/2022081505/554b2442b4c905a2058b463a/html5/thumbnails/39.jpg)
Regurgitant volume
Step 4– In PLAx measure the
diameter of the LVOT (cm).
– Calculate CSA of the LVOT (cm2)
• CSALVOT = 0.785 x (LVOT diameter)2
![Page 40: Valvular heart disease assessment of lesion severity](https://reader035.fdocuments.us/reader035/viewer/2022081505/554b2442b4c905a2058b463a/html5/thumbnails/40.jpg)
Regurgitant volume
Step 5
– In the Ap5 Ch view measure the VTI of the LVOT outflow (using PWD)
• VTILVOT (cm)
Step 6. Stroke volume
– SVLVOT = CSALVOT x VTILVOT
![Page 41: Valvular heart disease assessment of lesion severity](https://reader035.fdocuments.us/reader035/viewer/2022081505/554b2442b4c905a2058b463a/html5/thumbnails/41.jpg)
Regurgitant Volume/Fraction
Step 6– Mitral regurgitant volume (RV)(mL)
• RV =SVMV – SVLVOT
– Mild MR:<30 Mod MR:31-59– Severe MR:>60
Step 7– Mitral regurgitant Fraction (MF)(cm2)
• RF = RV / SVMV (x100)– Mild MR:<30 Mod MR:31-49– Severe MR:>50
![Page 42: Valvular heart disease assessment of lesion severity](https://reader035.fdocuments.us/reader035/viewer/2022081505/554b2442b4c905a2058b463a/html5/thumbnails/42.jpg)
Regurgitant orifice area
Step 8– Measure the VTI of the
mitral regurgitation VTIMR (cm) (using CWD)
– Calculate Regurgitant Orifice Area (ROA) in cm2
• ROA = RV / VTIMR
– Mild MR:<0.20– Mod MR:0.21-0.39– Severe MR:>0.40
![Page 43: Valvular heart disease assessment of lesion severity](https://reader035.fdocuments.us/reader035/viewer/2022081505/554b2442b4c905a2058b463a/html5/thumbnails/43.jpg)
Regurgitant Orifice Area PISA method
Step 1. Measure the radius of the hemisphere. (red/blue interface)
– PISA =2πr2 (cm2)
– Calculate regurgitant flow rate
– RFR mL/s =PISA X aliasing velocity
![Page 44: Valvular heart disease assessment of lesion severity](https://reader035.fdocuments.us/reader035/viewer/2022081505/554b2442b4c905a2058b463a/html5/thumbnails/44.jpg)
Regurgitant orifice area
Step 2. CWD of the mitral regurgitation. Measure peak velocity (VMR) in cm/s.
Calculate Regurgitant Orifice Area in cm2.
– ROA =Regurgitant flow rate / VMR
![Page 45: Valvular heart disease assessment of lesion severity](https://reader035.fdocuments.us/reader035/viewer/2022081505/554b2442b4c905a2058b463a/html5/thumbnails/45.jpg)
Common pitfalls
Measuring regurgitant jet area or VC width on colour doppler with inappropriate colour gain settings
Underestimating severity of eccentric jets on CFD. Failure to align the doppler beam with regurgitant flow
during CW doppler interrogation. Inaccurate measurement of mitral valve orifice area or
LVOT diameter when calculating RV. Trying to calculate RV when there is coexistant aortic
regurgitation. Failure to average several readings when the patient is in
AF.
![Page 46: Valvular heart disease assessment of lesion severity](https://reader035.fdocuments.us/reader035/viewer/2022081505/554b2442b4c905a2058b463a/html5/thumbnails/46.jpg)
Radionuclide angiography and MRIEvaluate LV function
Estimate the severity of regurgitation The regurgitant fraction can be estimated from the ratio of LV to RV (LV/RV) stroke volume
Cardiac catheterizationConfirm the diagnosis of MR and estimate its severity, evaluate cardiac function andpulmonary artery pressureCoronary angiography is performed todetermine presence of CAD prior to surgery
J Am Coll Cardiol. 1999;34:1137-44.
![Page 47: Valvular heart disease assessment of lesion severity](https://reader035.fdocuments.us/reader035/viewer/2022081505/554b2442b4c905a2058b463a/html5/thumbnails/47.jpg)
2014 AHA/ACC Valvular Heart Disease Guidelines
J Am Coll Cardiol. March 2014.Online first.
![Page 48: Valvular heart disease assessment of lesion severity](https://reader035.fdocuments.us/reader035/viewer/2022081505/554b2442b4c905a2058b463a/html5/thumbnails/48.jpg)
2014 AHA/ACC Valvular Heart Disease Guidelines
J Am Coll Cardiol. March 2014.Online first.
![Page 49: Valvular heart disease assessment of lesion severity](https://reader035.fdocuments.us/reader035/viewer/2022081505/554b2442b4c905a2058b463a/html5/thumbnails/49.jpg)
Aortic stenosis (AS)
EtiologyRHD Common, + AR and mitral valve disease
Degenerative calcific AS Common in the elderly, accompanied by calcification of the mitral annulus Congenital abnormalities Calcific stenosis of congenitally bicuspid aortic valve Congenital aortic stenosis
![Page 50: Valvular heart disease assessment of lesion severity](https://reader035.fdocuments.us/reader035/viewer/2022081505/554b2442b4c905a2058b463a/html5/thumbnails/50.jpg)
Hemodynamic changesNormal aortic orifice area (AOA): 3.0~4.0 cm2AOA ≤1.0cm2, LVSP↑, with significant transvalvular gradient
Compensation AS→LV pressure load↑
Concentric LVH→compliance↓→LVEDP↑→LAH
Maintain systolic wall stress and CO ↑LVEDV
Decompensation LVEDV↑→wall stress↑, myocardial ischemia, fibrosis → left HF
![Page 51: Valvular heart disease assessment of lesion severity](https://reader035.fdocuments.us/reader035/viewer/2022081505/554b2442b4c905a2058b463a/html5/thumbnails/51.jpg)
Classic symptom triad
Dyspnea Angina Syncope
![Page 52: Valvular heart disease assessment of lesion severity](https://reader035.fdocuments.us/reader035/viewer/2022081505/554b2442b4c905a2058b463a/html5/thumbnails/52.jpg)
Classic symptom triad
Once any of these classic symptoms develop, prognosis dramatically worsens.
Thus, within 5 years of the development of angina, approximately 50% of patients will die unless aortic valve replacement is performed.
For syncope, 50% survival is 3 years For congestive heart failure, 50% survival is only 2
years unless the valve is replaced. Angina 5yrs, Syncope 3yrs, and CHF 2yrs.
![Page 53: Valvular heart disease assessment of lesion severity](https://reader035.fdocuments.us/reader035/viewer/2022081505/554b2442b4c905a2058b463a/html5/thumbnails/53.jpg)
Severe AS
Triad of angina,dyspnoea and syncope Heaving apex Slow rising small volume pulse Reverse splitting of S2 Long duration of systolic murmur Late peaking of murmur Presence of S4
![Page 54: Valvular heart disease assessment of lesion severity](https://reader035.fdocuments.us/reader035/viewer/2022081505/554b2442b4c905a2058b463a/html5/thumbnails/54.jpg)
Laboratory examination
ECGSevere: LVH and secondary ST-T changes,
LA↑ , arrhythmias
Radiological findingsNormal size or slightly enlarged heart
Calcification of the aortic valve
Poststenotic dilatation of the ascending aorta
Pulmonary congestion
![Page 55: Valvular heart disease assessment of lesion severity](https://reader035.fdocuments.us/reader035/viewer/2022081505/554b2442b4c905a2058b463a/html5/thumbnails/55.jpg)
EchocardiographyEstablish a diagnosis, and determine the severity of AS
M-mode and 2D echo Observe aortic valve opening, thickening and calcificationHelpful in determining the etiology of AS
Also invaluable in detecting associated mitral valve disease and in assessing LV performance, hypertrophy, and dilatation
Eur J Echocardiogr. 2009;10:1-25.
![Page 56: Valvular heart disease assessment of lesion severity](https://reader035.fdocuments.us/reader035/viewer/2022081505/554b2442b4c905a2058b463a/html5/thumbnails/56.jpg)
Doppler echo
Allows calculation of the aortic valve gradient
Estimate the severity of the stenosis < 20 mmHg Mild AS MPG 20~40 mmHg Moderate AS > 40 mmHg Severe AS
Color Doppler flow imaging is helpful in the detection and determination of the severity of any accompanying aortic regurgitation
Eur J Echocardiogr. 2009;10:1-25.
![Page 57: Valvular heart disease assessment of lesion severity](https://reader035.fdocuments.us/reader035/viewer/2022081505/554b2442b4c905a2058b463a/html5/thumbnails/57.jpg)
Enriquez-Sarano, M. et al. N Engl J Med 2004;351:1539-1546
Jet of Aortic Regurgitation, as Shown by Color-Flow Imaging
![Page 58: Valvular heart disease assessment of lesion severity](https://reader035.fdocuments.us/reader035/viewer/2022081505/554b2442b4c905a2058b463a/html5/thumbnails/58.jpg)
Enriquez-Sarano, M. et al. N Engl J Med 2004;351:1539-1546
Classification of the Severity of Aortic Regurgitation
![Page 59: Valvular heart disease assessment of lesion severity](https://reader035.fdocuments.us/reader035/viewer/2022081505/554b2442b4c905a2058b463a/html5/thumbnails/59.jpg)
Enriquez-Sarano, M. et al. N Engl J Med 2004;351:1539-1546
Quantitation of Aortic Regurgitation by the Convergence of the Proximal Flow
![Page 60: Valvular heart disease assessment of lesion severity](https://reader035.fdocuments.us/reader035/viewer/2022081505/554b2442b4c905a2058b463a/html5/thumbnails/60.jpg)
![Page 61: Valvular heart disease assessment of lesion severity](https://reader035.fdocuments.us/reader035/viewer/2022081505/554b2442b4c905a2058b463a/html5/thumbnails/61.jpg)
![Page 62: Valvular heart disease assessment of lesion severity](https://reader035.fdocuments.us/reader035/viewer/2022081505/554b2442b4c905a2058b463a/html5/thumbnails/62.jpg)
![Page 63: Valvular heart disease assessment of lesion severity](https://reader035.fdocuments.us/reader035/viewer/2022081505/554b2442b4c905a2058b463a/html5/thumbnails/63.jpg)
Cardiac catheterization
Determine the severity of AS by measuring systolic LV and aortic pressure simultaneously, and calculating the valve area
An average pressure gradient of > 40mmHg or peak pressure gradient of ≥ 70mmHg represent severe AS
Coronary angiography is performed in most adults to assess for concomitant coronary disease
![Page 64: Valvular heart disease assessment of lesion severity](https://reader035.fdocuments.us/reader035/viewer/2022081505/554b2442b4c905a2058b463a/html5/thumbnails/64.jpg)
Cath data
“Pull back” tracing can be used in pt with NSR but not accurate in irregular rhythms or low-out put states.
In low cardiac output, the stenosis may be severe, with a mean gradient <50mm Hg per echo.
Gorlin equation can be used to calculate AVA from pressure gradients, independent of CO.
AVA= (1000)(CO) (44)(SEP)(HR)(√P)
![Page 65: Valvular heart disease assessment of lesion severity](https://reader035.fdocuments.us/reader035/viewer/2022081505/554b2442b4c905a2058b463a/html5/thumbnails/65.jpg)
![Page 66: Valvular heart disease assessment of lesion severity](https://reader035.fdocuments.us/reader035/viewer/2022081505/554b2442b4c905a2058b463a/html5/thumbnails/66.jpg)
2014 AHA/ACC Valvular Heart Disease Guidelines
J Am Coll Cardiol. March 2014.Online first.
![Page 67: Valvular heart disease assessment of lesion severity](https://reader035.fdocuments.us/reader035/viewer/2022081505/554b2442b4c905a2058b463a/html5/thumbnails/67.jpg)
2014 AHA/ACC Valvular Heart Disease Guidelines
J Am Coll Cardiol. March 2014.Online first.
![Page 68: Valvular heart disease assessment of lesion severity](https://reader035.fdocuments.us/reader035/viewer/2022081505/554b2442b4c905a2058b463a/html5/thumbnails/68.jpg)
Aortic regurgitation (AR)
Etiology
Primary disease of the aortic valves
and/ or aortic root
![Page 69: Valvular heart disease assessment of lesion severity](https://reader035.fdocuments.us/reader035/viewer/2022081505/554b2442b4c905a2058b463a/html5/thumbnails/69.jpg)
Aortic valve disease① RHD : most common, about 2/3 + AS and/or mitral valve disease
② Infective endocarditis③ Congenital deformity: bicuspid valves
④ Myxomatous degeneration of the aortic valve
Aortic root dilatation① Marfan syndrome② Aortic dissection (involve annulus or leaflets) ③ Syphilitic aortitis
Clinical practice: aortic regurgitation. NEngl J Med. 2004;351:1539-1546.
![Page 70: Valvular heart disease assessment of lesion severity](https://reader035.fdocuments.us/reader035/viewer/2022081505/554b2442b4c905a2058b463a/html5/thumbnails/70.jpg)
Valvular Abnormalities leading to AR
Nodular Rheumatic Disease Aortic Root Dilation
Endocarditis
![Page 71: Valvular heart disease assessment of lesion severity](https://reader035.fdocuments.us/reader035/viewer/2022081505/554b2442b4c905a2058b463a/html5/thumbnails/71.jpg)
Hemodynamic changes
Chronic ARCompensation : AR→LV volume↑→ LV↑, LVEDV↑→ SV↑(CO)
Decompensation: LV systolic dysfunction→ LV failure (EF↓, LVESV↑)
Acute ARAR →LV volume↑→ LVDP↑→ LAP↑ ↓ ↓CO↓ pulmonary congestion pulmonary edema
Clinical practice: aortic regurgitation. NEngl J Med. 2004;351:1539-1546.
![Page 72: Valvular heart disease assessment of lesion severity](https://reader035.fdocuments.us/reader035/viewer/2022081505/554b2442b4c905a2058b463a/html5/thumbnails/72.jpg)
Clinical manifestationsSymptomsChronic ARAsymptomatic for many yearsPalpitation, precordial discomfort, head pounding
(related to SV↑)LV failure (dyspnea, fatigue): occur at late stage
Angina pectoris or chest pain: less common
Acute ARmild—no symptomsevere—Acute LV failure and hypotension (pulmonary edema)
Clinical practice: aortic regurgitation. NEngl J Med. 2004;351:1539-1546.
![Page 73: Valvular heart disease assessment of lesion severity](https://reader035.fdocuments.us/reader035/viewer/2022081505/554b2442b4c905a2058b463a/html5/thumbnails/73.jpg)
Physical examinationChronic, severe AR
① Peripheral arterial signs: Owing to wide pulse pressure: SBP↑, DBP↓
Water-hammer pulse Water-hammer pulse (rapid rise and fall)
“Pistol shot soundsPistol shot sounds” (booming systolic & diastolic sounds heard over femoral artery) Duroziez’s signDuroziez’s sign (systolic, diastolic murmur over partially compressed femoral artery) Quincke’s sign Quincke’s sign (subungual capillary pulsations)
de Musset’s sign de Musset’s sign (head bobs with each heartbeat )
② Apical impulse: diffuse and forceful, displaced laterally and inferiorly (hyperactive, enlarged LV)
③ Heart sound: An S3 gallop is common with LV failure
Clinical practice: aortic regurgitation. NEngl J Med. 2004;351:1539-1546.
![Page 74: Valvular heart disease assessment of lesion severity](https://reader035.fdocuments.us/reader035/viewer/2022081505/554b2442b4c905a2058b463a/html5/thumbnails/74.jpg)
④ Heart murmurs
Aortic diastolic murmur:Aortic diastolic murmur:
High-pitched, blowing, decrescendo pattern
When AR is due to primary valvular disease, the diastolic murmur is best heard along the left sternal border in the 3rd and 4th intercostal spaces
However, when it is due mainly to dilatation of the ascending aorta, the murmur is often more readily audible along the right upper sternal border
Austin-Flint murmur: apical mid or late diastolic low-pitched murmur: common in severe AR, owing to partial closure of MV by the regurgitant jet
Circulation. 2005;112(1):125-134.
![Page 75: Valvular heart disease assessment of lesion severity](https://reader035.fdocuments.us/reader035/viewer/2022081505/554b2442b4c905a2058b463a/html5/thumbnails/75.jpg)
Ejection systolic murmur: common harsh at the base of the heart accompanied by a systolic thrill
Acute ARS1 soft or absent , P2↑ , S3 and S4AR murmur: lower pitched and shorter than that of chronic ARAustin-Flint murmur: brief
Circulation. 2005;112(1):125-134.
![Page 76: Valvular heart disease assessment of lesion severity](https://reader035.fdocuments.us/reader035/viewer/2022081505/554b2442b4c905a2058b463a/html5/thumbnails/76.jpg)
Laboratory examinationECG Acute: sinus tachycardia; nonspecific ST-T changes
Chronic: LV enlargement and hypertrophy, arrhythmias
Circulation. 2005;112(1):125-134.
![Page 77: Valvular heart disease assessment of lesion severity](https://reader035.fdocuments.us/reader035/viewer/2022081505/554b2442b4c905a2058b463a/html5/thumbnails/77.jpg)
Radiological findings
Acute AR: cardiac size normal or slightly enlarge,signs of pulmonary congestion, pulmonary edema
Chronic: LV enlargement, associated with dilatation of the ascending aorta Severe, aneurysmal dilatation of the aorta suggests aortic root disease Marfan syndrome)
Pulmonary congestion ( LV heart failure )
Chronic Acute
LVE with normal pulmonaryvasculature
Normal size LV with pulmonaryvascular congestion
![Page 78: Valvular heart disease assessment of lesion severity](https://reader035.fdocuments.us/reader035/viewer/2022081505/554b2442b4c905a2058b463a/html5/thumbnails/78.jpg)
Echocardiography Confirm diagnosis, estimate severity, identify the cause
2-D echo: Structural changes of the valve leaflets and/or aortic root
M mode echo: Diastolic fluttering of the anterior leaflet of the mitral valve is an important echocardiographic finding in AR Serial assessments of LV size and function
Doppler echo: Sensitive, accurate noninvasive technique for detecting AR
LVOT diastolic regurgitant jet, estimate the severity of AR
Cardiac catheterization Quantify the severity of AR Evaluate the coronary and aortic root anatomy
J Am Soc Echocardiogr.2003;16:777-802.
![Page 79: Valvular heart disease assessment of lesion severity](https://reader035.fdocuments.us/reader035/viewer/2022081505/554b2442b4c905a2058b463a/html5/thumbnails/79.jpg)
AMVL fluttering
Color Flow – top mild, bottom moderate
![Page 80: Valvular heart disease assessment of lesion severity](https://reader035.fdocuments.us/reader035/viewer/2022081505/554b2442b4c905a2058b463a/html5/thumbnails/80.jpg)
Regurgitant jet width/LVOT diameter ratio greater than or equal to 60 percent
![Page 81: Valvular heart disease assessment of lesion severity](https://reader035.fdocuments.us/reader035/viewer/2022081505/554b2442b4c905a2058b463a/html5/thumbnails/81.jpg)
Vena contracta greater than 6 mm
![Page 82: Valvular heart disease assessment of lesion severity](https://reader035.fdocuments.us/reader035/viewer/2022081505/554b2442b4c905a2058b463a/html5/thumbnails/82.jpg)
Regurgitant jet area/LVOT area ratio greater than or equal to 60 percent
![Page 83: Valvular heart disease assessment of lesion severity](https://reader035.fdocuments.us/reader035/viewer/2022081505/554b2442b4c905a2058b463a/html5/thumbnails/83.jpg)
![Page 84: Valvular heart disease assessment of lesion severity](https://reader035.fdocuments.us/reader035/viewer/2022081505/554b2442b4c905a2058b463a/html5/thumbnails/84.jpg)
Holodiastolic flow reversal in the descending thoracic or abdominal aorta
![Page 85: Valvular heart disease assessment of lesion severity](https://reader035.fdocuments.us/reader035/viewer/2022081505/554b2442b4c905a2058b463a/html5/thumbnails/85.jpg)
![Page 86: Valvular heart disease assessment of lesion severity](https://reader035.fdocuments.us/reader035/viewer/2022081505/554b2442b4c905a2058b463a/html5/thumbnails/86.jpg)
vitrag24-www.medicalgeek.com
Assessing Severity of AR
Assess severity by impact on peripheral signs and LV- Duration of murmur >2/3 of diastole Bisferiens pulse Hills sign>60 mmHg Apical impulse down & out Austin flint murmur Marked peripheral sign
Circulation. 2005;112(1):125-134.
![Page 87: Valvular heart disease assessment of lesion severity](https://reader035.fdocuments.us/reader035/viewer/2022081505/554b2442b4c905a2058b463a/html5/thumbnails/87.jpg)
Features AS > AR AR > AS
Symptoms:Anginal pain, blackoutPalpitation
++++
++++
Pulse Low volumeBisferians pulse
High volumeCorrigan’s pulse
Pulse pressure Normal to low Wide
Peripheral signs +/- +
Apex Heaving Hyperdynamic
Thril Always systolic Rarely
S3 Absent May be present
S4 May be present Absent
Ejection click Present Rare
Diastolic murmur Very short Classic murmur of AR
Systolic murmur Classic murmur of AS Function systolic murmur +/-
Chest X-Ray Calcification + Cardiomegaly
ECG Pressure overload Volume overload
![Page 88: Valvular heart disease assessment of lesion severity](https://reader035.fdocuments.us/reader035/viewer/2022081505/554b2442b4c905a2058b463a/html5/thumbnails/88.jpg)
vitrag24-www.medicalgeek.com
![Page 89: Valvular heart disease assessment of lesion severity](https://reader035.fdocuments.us/reader035/viewer/2022081505/554b2442b4c905a2058b463a/html5/thumbnails/89.jpg)
2014 AHA/ACC Valvular Heart Disease Guidelines
J Am Coll Cardiol. March 2014.Online first.
![Page 90: Valvular heart disease assessment of lesion severity](https://reader035.fdocuments.us/reader035/viewer/2022081505/554b2442b4c905a2058b463a/html5/thumbnails/90.jpg)
2014 AHA/ACC Valvular Heart Disease Guidelines
J Am Coll Cardiol. March 2014.Online first.
![Page 91: Valvular heart disease assessment of lesion severity](https://reader035.fdocuments.us/reader035/viewer/2022081505/554b2442b4c905a2058b463a/html5/thumbnails/91.jpg)
Tricuspid stenosis
Uncommom valvular lesion Rheumatic heart disease Congenital TS Carcinoid syndrome
![Page 92: Valvular heart disease assessment of lesion severity](https://reader035.fdocuments.us/reader035/viewer/2022081505/554b2442b4c905a2058b463a/html5/thumbnails/92.jpg)
Severe TS
Giant a wave in JVP Duration of diastolic murmur over tricuspid
valve Signs of right heart failure
N Engl J Med. 1997;337:32-41.
![Page 93: Valvular heart disease assessment of lesion severity](https://reader035.fdocuments.us/reader035/viewer/2022081505/554b2442b4c905a2058b463a/html5/thumbnails/93.jpg)
ECG- Absence of evidence of RVH Right atrial abnormality Chest X ray Prominence of right atrium and SVC
N Engl J Med. 1997;337:32-41.
![Page 94: Valvular heart disease assessment of lesion severity](https://reader035.fdocuments.us/reader035/viewer/2022081505/554b2442b4c905a2058b463a/html5/thumbnails/94.jpg)
2014 AHA/ACC Valvular Heart Disease Guidelines
J Am Coll Cardiol. March 2014.Online first.
![Page 95: Valvular heart disease assessment of lesion severity](https://reader035.fdocuments.us/reader035/viewer/2022081505/554b2442b4c905a2058b463a/html5/thumbnails/95.jpg)
Tricuspid regurgitation Primary disorders of the tricuspid apparatus Rheumatic disease Prolapse Congenital disease (Ebstein’s) IE Radiation Carcinoid Blunt chest wall trauma RV endomyocardial biopsy related trauma Intra-annular RV pacemaker or implantable cardioverter-
defibrillator leads.
N Engl J Med. 1997;337:32-41.
![Page 96: Valvular heart disease assessment of lesion severity](https://reader035.fdocuments.us/reader035/viewer/2022081505/554b2442b4c905a2058b463a/html5/thumbnails/96.jpg)
Approximately 80% of cases of significant TR are
functional in nature and related to tricuspid
annular dilation and leaflet tethering in the setting
of RV remodeling due to pressure and/or volume
overload.
J Am Soc Echocardiogr.2003;16:777-802.
![Page 97: Valvular heart disease assessment of lesion severity](https://reader035.fdocuments.us/reader035/viewer/2022081505/554b2442b4c905a2058b463a/html5/thumbnails/97.jpg)
Tricuspid stenosis
![Page 98: Valvular heart disease assessment of lesion severity](https://reader035.fdocuments.us/reader035/viewer/2022081505/554b2442b4c905a2058b463a/html5/thumbnails/98.jpg)
2014 AHA/ACC Valvular Heart Disease Guidelines
J Am Coll Cardiol. March 2014.Online first.
![Page 99: Valvular heart disease assessment of lesion severity](https://reader035.fdocuments.us/reader035/viewer/2022081505/554b2442b4c905a2058b463a/html5/thumbnails/99.jpg)
2014 AHA/ACC Valvular Heart Disease Guidelines
J Am Coll Cardiol. March 2014.Online first.
![Page 100: Valvular heart disease assessment of lesion severity](https://reader035.fdocuments.us/reader035/viewer/2022081505/554b2442b4c905a2058b463a/html5/thumbnails/100.jpg)
Pulmonary stenosis
Pulmonic stenosis is essentially a congenital disorder.
Less common etiologies include carcinoid and obstructing vegetations or tumors.
Assessment with TTE alone is usually sufficient for diagnosis and clinical decision making.
N Engl J Med. 1997;337:32-41.
![Page 101: Valvular heart disease assessment of lesion severity](https://reader035.fdocuments.us/reader035/viewer/2022081505/554b2442b4c905a2058b463a/html5/thumbnails/101.jpg)
Pulmonary stenosis
![Page 102: Valvular heart disease assessment of lesion severity](https://reader035.fdocuments.us/reader035/viewer/2022081505/554b2442b4c905a2058b463a/html5/thumbnails/102.jpg)
2014 AHA/ACC Valvular Heart Disease Guidelines
J Am Coll Cardiol. March 2014.Online first.
![Page 103: Valvular heart disease assessment of lesion severity](https://reader035.fdocuments.us/reader035/viewer/2022081505/554b2442b4c905a2058b463a/html5/thumbnails/103.jpg)
Pulmonary regurgitation
Mild-to-moderate PR seen on echocardiography is common and does not require further follow-up or intervention if asymptomatic with normal RV size and function.
Significant PR in patients is uncommon. Primary PR that follows in the wake of childhood surgery
for tetralogy of Fallot or other congenital lesions may progress insidiously
J Am Soc Echocardiogr.2003;16:777-802.
![Page 104: Valvular heart disease assessment of lesion severity](https://reader035.fdocuments.us/reader035/viewer/2022081505/554b2442b4c905a2058b463a/html5/thumbnails/104.jpg)
2014 AHA/ACC Valvular Heart Disease Guidelines
J Am Coll Cardiol. March 2014.Online first.
![Page 105: Valvular heart disease assessment of lesion severity](https://reader035.fdocuments.us/reader035/viewer/2022081505/554b2442b4c905a2058b463a/html5/thumbnails/105.jpg)
We urgently need research on almost every aspect of VHD to ensure that patients who already have VHD receive optimal therapy and to prevent VHD in those at risk.
Approaches to improving outcomes in patients with VHD include –
1) National and international registries and RCTs
2) Continuous evaluation of outcomes data at each Heart Valve Center of Excellence
3) Focus on patient-centric care with involvement of the patient in the decision-making process.
![Page 106: Valvular heart disease assessment of lesion severity](https://reader035.fdocuments.us/reader035/viewer/2022081505/554b2442b4c905a2058b463a/html5/thumbnails/106.jpg)
THANK YOU
THANK YOU